共 50 条
- [1] Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studyEUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)Borisov, Sergey E.Dheda, KeertanEnwerem, MartinLeyet, Rodolfo RomeroD'Ambrosio, LiaCentis, RosellaSotgiu, GiovanniTiberi, SimonAlffenaar, Jan-WillemMaryandyshev, AndreyBelilovski, EvgenyGanatra, ShashankSkrahina, AlenaAkkerman, OnnoAleksa, AlenaAmale, RohitArtsukevich, JaninaBruchfeld, JudithCaminero, Jose A.Carpena Martinez, IsabelCodecasa, LuigiDalcolmo, MargarethDenholm, JustinDouglas, PaulDuarte, RaquelEsmail, AliasgarFadul, MohammedFilippov, AlexeyForsman, Lina DaviesGaga, MinaGarcia-Fuertes, Julia-AmarantaGarcia-Garcia, Jose-MariaGualano, GinaJonsson, JerkerKunst, HeinkeLau, Jillian S.Mastrapa, Barbara LazaroTroya, Jorge Lazaro TeranManga, SeleneManika, KaterinaGonzalez Montaner, PabloMullerpattan, JaiOelofse, SuzetteOrtelli, MartinaJuan Palmero, DomingoPalmieri, FabrizioPapalia, AntonellaPapavasileiou, ApostolosPayen, Marie-ChristinePontali, Emanuele
- [2] Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre studyCLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (04) : 597 - 602Gao, M.Gao, J.Xie, L.Wu, G.Chen, W.Chen, Y.Pei, Y.Li, G.Liu, Y.Shu, W.Fan, L.Wu, Q.Du, J.Chen, X.Tang, P.Xiong, Y.Li, M.Cai, Q.Jin, L.Mei, Z.Pang, Y.Li, L.
- [3] Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyInfectious Diseases of Poverty, 10Jing-Tao GaoJuan DuGui-Hui WuYi PeiMeng-Qiu GaoLeonardo MartinezLin FanWei ChenLi XieYu ChenHua WangLong JinGuo-Bao LiPei-Lan ZongYu XiongQian-Hong WuMing-Wu LiXiao-Feng YanYan-Fang MiaoQing-Shan CaiXin-Jie LiDa-Peng BaiShu-Jun GengGuo-Li YangPei-Jun TangYi ZengXiao-Hong ChenTong-Xia LiCui CaiYun ZhouMa ZhuoJian-Yun WangWen-Long GuanLin XuJi-Chan ShiWei ShuLi-Li ChengFei TengYu-Jia NingShi-Heng XieYu-Xian SunLi-Jie ZhangYu-Hong Liu
- [4] Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyINFECTIOUS DISEASES OF POVERTY, 2021, 10 (01)Gao, Jing-TaoDu, JuanWu, Gui-HuiPei, YiGao, Meng-QiuMartinez, LeonardoFan, LinChen, WeiXie, LiChen, YuWang, HuaJin, LongLi, Guo-BaoZong, Pei-LanXiong, YuWu, Qian-HongLi, Ming-WuYan, Xiao-FengMiao, Yan-FangCai, Qing-ShanLi, Xin-JieBai, Da-PengGeng, Shu-JunYang, Guo-LiTang, Pei-JunZeng, YiChen, Xiao-HongLi, Tong-XiaCai, CuiZhou, YunZhuo, MaWang, Jian-YunGuan, Wen-LongXu, LinShi, Ji-ChanShu, WeiCheng, Li-LiTeng, FeiNing, Yu-JiaXie, Shi-HengSun, Yu-XianZhang, Li-JieLiu, Yu-Hong
- [5] Treatment outcome in patients with MDR-TB treated with bedaquiline containing regimens, Republic of MoldovaEUROPEAN RESPIRATORY JOURNAL, 2020, 56Chesov, DumitruHeyckendorf, JanReiman, MajaAlexandru, SofiaDonica, AnaSov, Elena CheCrudu, ValeriuBotnaru, VictorLange, Christoph
- [6] Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort StudyInfectious Diseases and Therapy, 2021, 10 : 457 - 470Li ShiJingtao GaoMengqiu GaoPing DengShu ChenMinfu HeWenjun FengXiaoyun YangYunhui HuangFang HeYumeng HuLiping LeiXuelian LiJuan DuXiaomeng HuZhi LiuPeijun TangJunfeng HanHua WangYi HanWei ShuYuxian SunYi PeiYuhong Liu
- [7] The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimensBMC INFECTIOUS DISEASES, 2019, 19 (01)Khan, UzmaHuerga, HelenaKhan, Aamir J.Mitnick, Carole D.Hewison, CatherineVaraine, FrancisBastard, MathieuRich, MichaelFranke, Molly F.Atwood, SidneyKhan, Palwasha Y.Seung, Kwonjune J.
- [8] Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East ChinaBMC Infectious Diseases, 22Shao-Jun ZhangYan YangWen-Wen SunZhong-Shun ZhangHe-Ping XiaoYu-Ping LiZhe-Min ZhangLin Fan
- [9] The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimensBMC Infectious Diseases, 19Uzma KhanHelena HuergaAamir J. KhanCarole D. MitnickCatherine HewisonFrancis VaraineMathieu BastardMichael RichMolly F. FrankeSidney AtwoodPalwasha Y. KhanKwonjune J. Seung
- [10] Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatmentFUTURE MICROBIOLOGY, 2015, 10 (08) : 1257 - 1260Srikrishna, GeethaGupta, ShashankDooley, Kelly E.Bishai, William R.